カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のニボルマブ注射市場2022年：100IU、50IU、その他

◆英語タイトル：Global Nivolumab Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8906 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：91 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ニボルマブ注射市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のニボルマブ注射の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ニボルマブ注射市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・100IU、50IU、その他

用途別セグメントは次のように区分されます。
・切除不能黒色腫、転移性黒色腫、転移性扁平上皮NSCLC、古典的ホジキンリンパ腫、腎細胞癌、その他

世界のニボルマブ注射市場の主要な市場プレーヤーは以下のとおりです。
・AbbVie、Allergan、Ono Pharmaceutical、Sinopharm、Bristol-Myers Squibb

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ニボルマブ注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なニボルマブ注射メーカーの企業概要、2019年～2022年までのニボルマブ注射の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なニボルマブ注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ニボルマブ注射の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのニボルマブ注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのニボルマブ注射市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびニボルマブ注射の産業チェーンを掲載しています。
・第13、14、15章では、ニボルマブ注射の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：AbbVie、Allergan、Ono Pharmaceutical、Sinopharm、Bristol-Myers Squibb
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：100IU、50IU、その他
・用途別分析2017年-2028年：切除不能黒色腫、転移性黒色腫、転移性扁平上皮NSCLC、古典的ホジキンリンパ腫、腎細胞癌、その他
・ニボルマブ注射の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ニボルマブ注射のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ニボルマブ注射のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ニボルマブ注射の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ニボルマブ注射の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Nivolumab Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nivolumab Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Unresectable Melanoma accounting for % of the Nivolumab Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 100IU segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nivolumab Injection include AbbVie, Allergan, Ono Pharmaceutical, Sinopharm, and Bristol-Myers Squibb, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nivolumab Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
100IU
50IU
Other
Market segment by Application can be divided into
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
The key market players for global Nivolumab Injection market are listed below:
AbbVie
Allergan
Ono Pharmaceutical
Sinopharm
Bristol-Myers Squibb
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nivolumab Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nivolumab Injection, with price, sales, revenue and global market share of Nivolumab Injection from 2019 to 2022.
Chapter 3, the Nivolumab Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nivolumab Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nivolumab Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nivolumab Injection.
Chapter 13, 14, and 15, to describe Nivolumab Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Nivolumab Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nivolumab Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 100IU
1.2.3 50IU
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Nivolumab Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Unresectable Melanoma
1.3.3 Metastatic Melanoma
1.3.4 Metastatic Squamous NSCLC
1.3.5 Classical Hodgkin Lymphoma
1.3.6 Renal Cell Carcinoma
1.3.7 Other
1.4 Global Nivolumab Injection Market Size & Forecast
1.4.1 Global Nivolumab Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nivolumab Injection Sales in Volume (2017-2028)
1.4.3 Global Nivolumab Injection Price (2017-2028)
1.5 Global Nivolumab Injection Production Capacity Analysis
1.5.1 Global Nivolumab Injection Total Production Capacity (2017-2028)
1.5.2 Global Nivolumab Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nivolumab Injection Market Drivers
1.6.2 Nivolumab Injection Market Restraints
1.6.3 Nivolumab Injection Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Nivolumab Injection Product and Services
2.1.4 AbbVie Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Nivolumab Injection Product and Services
2.2.4 Allergan Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ono Pharmaceutical
2.3.1 Ono Pharmaceutical Details
2.3.2 Ono Pharmaceutical Major Business
2.3.3 Ono Pharmaceutical Nivolumab Injection Product and Services
2.3.4 Ono Pharmaceutical Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sinopharm
2.4.1 Sinopharm Details
2.4.2 Sinopharm Major Business
2.4.3 Sinopharm Nivolumab Injection Product and Services
2.4.4 Sinopharm Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Nivolumab Injection Product and Services
2.5.4 Bristol-Myers Squibb Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nivolumab Injection Breakdown Data by Manufacturer
3.1 Global Nivolumab Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nivolumab Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nivolumab Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Nivolumab Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Nivolumab Injection Manufacturer Market Share in 2021
3.5 Global Nivolumab Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nivolumab Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nivolumab Injection Market Size by Region
4.1.1 Global Nivolumab Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Nivolumab Injection Revenue by Region (2017-2028)
4.2 North America Nivolumab Injection Revenue (2017-2028)
4.3 Europe Nivolumab Injection Revenue (2017-2028)
4.4 Asia-Pacific Nivolumab Injection Revenue (2017-2028)
4.5 South America Nivolumab Injection Revenue (2017-2028)
4.6 Middle East and Africa Nivolumab Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nivolumab Injection Sales in Volume by Type (2017-2028)
5.2 Global Nivolumab Injection Revenue by Type (2017-2028)
5.3 Global Nivolumab Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nivolumab Injection Sales in Volume by Application (2017-2028)
6.2 Global Nivolumab Injection Revenue by Application (2017-2028)
6.3 Global Nivolumab Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nivolumab Injection Sales by Type (2017-2028)
7.2 North America Nivolumab Injection Sales by Application (2017-2028)
7.3 North America Nivolumab Injection Market Size by Country
7.3.1 North America Nivolumab Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Nivolumab Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nivolumab Injection Sales by Type (2017-2028)
8.2 Europe Nivolumab Injection Sales by Application (2017-2028)
8.3 Europe Nivolumab Injection Market Size by Country
8.3.1 Europe Nivolumab Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Nivolumab Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nivolumab Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Nivolumab Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Nivolumab Injection Market Size by Region
9.3.1 Asia-Pacific Nivolumab Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nivolumab Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nivolumab Injection Sales by Type (2017-2028)
10.2 South America Nivolumab Injection Sales by Application (2017-2028)
10.3 South America Nivolumab Injection Market Size by Country
10.3.1 South America Nivolumab Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Nivolumab Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nivolumab Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Nivolumab Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Nivolumab Injection Market Size by Country
11.3.1 Middle East & Africa Nivolumab Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nivolumab Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nivolumab Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nivolumab Injection
12.3 Nivolumab Injection Production Process
12.4 Nivolumab Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nivolumab Injection Typical Distributors
13.3 Nivolumab Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Nivolumab Injection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nivolumab Injection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Nivolumab Injection Product and Services
Table 6. AbbVie Nivolumab Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Allergan Basic Information, Manufacturing Base and Competitors
Table 8. Allergan Major Business
Table 9. Allergan Nivolumab Injection Product and Services
Table 10. Allergan Nivolumab Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Ono Pharmaceutical Major Business
Table 13. Ono Pharmaceutical Nivolumab Injection Product and Services
Table 14. Ono Pharmaceutical Nivolumab Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sinopharm Basic Information, Manufacturing Base and Competitors
Table 16. Sinopharm Major Business
Table 17. Sinopharm Nivolumab Injection Product and Services
Table 18. Sinopharm Nivolumab Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Major Business
Table 21. Bristol-Myers Squibb Nivolumab Injection Product and Services
Table 22. Bristol-Myers Squibb Nivolumab Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Nivolumab Injection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 24. Global Nivolumab Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Nivolumab Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Nivolumab Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Nivolumab Injection Production Site of Key Manufacturer
Table 28. Nivolumab Injection New Entrant and Capacity Expansion Plans
Table 29. Nivolumab Injection Mergers & Acquisitions in the Past Five Years
Table 30. Global Nivolumab Injection Sales by Region (2017-2022) & (K Units)
Table 31. Global Nivolumab Injection Sales by Region (2023-2028) & (K Units)
Table 32. Global Nivolumab Injection Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Nivolumab Injection Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Nivolumab Injection Sales by Type (2017-2022) & (K Units)
Table 35. Global Nivolumab Injection Sales by Type (2023-2028) & (K Units)
Table 36. Global Nivolumab Injection Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Nivolumab Injection Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Nivolumab Injection Price by Type (2017-2022) & (US$/Unit)
Table 39. Global Nivolumab Injection Price by Type (2023-2028) & (US$/Unit)
Table 40. Global Nivolumab Injection Sales by Application (2017-2022) & (K Units)
Table 41. Global Nivolumab Injection Sales by Application (2023-2028) & (K Units)
Table 42. Global Nivolumab Injection Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Nivolumab Injection Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Nivolumab Injection Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Nivolumab Injection Price by Application (2023-2028) & (US$/Unit)
Table 46. North America Nivolumab Injection Sales by Country (2017-2022) & (K Units)
Table 47. North America Nivolumab Injection Sales by Country (2023-2028) & (K Units)
Table 48. North America Nivolumab Injection Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Nivolumab Injection Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Nivolumab Injection Sales by Type (2017-2022) & (K Units)
Table 51. North America Nivolumab Injection Sales by Type (2023-2028) & (K Units)
Table 52. North America Nivolumab Injection Sales by Application (2017-2022) & (K Units)
Table 53. North America Nivolumab Injection Sales by Application (2023-2028) & (K Units)
Table 54. Europe Nivolumab Injection Sales by Country (2017-2022) & (K Units)
Table 55. Europe Nivolumab Injection Sales by Country (2023-2028) & (K Units)
Table 56. Europe Nivolumab Injection Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Nivolumab Injection Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Nivolumab Injection Sales by Type (2017-2022) & (K Units)
Table 59. Europe Nivolumab Injection Sales by Type (2023-2028) & (K Units)
Table 60. Europe Nivolumab Injection Sales by Application (2017-2022) & (K Units)
Table 61. Europe Nivolumab Injection Sales by Application (2023-2028) & (K Units)
Table 62. Asia-Pacific Nivolumab Injection Sales by Region (2017-2022) & (K Units)
Table 63. Asia-Pacific Nivolumab Injection Sales by Region (2023-2028) & (K Units)
Table 64. Asia-Pacific Nivolumab Injection Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Nivolumab Injection Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Nivolumab Injection Sales by Type (2017-2022) & (K Units)
Table 67. Asia-Pacific Nivolumab Injection Sales by Type (2023-2028) & (K Units)
Table 68. Asia-Pacific Nivolumab Injection Sales by Application (2017-2022) & (K Units)
Table 69. Asia-Pacific Nivolumab Injection Sales by Application (2023-2028) & (K Units)
Table 70. South America Nivolumab Injection Sales by Country (2017-2022) & (K Units)
Table 71. South America Nivolumab Injection Sales by Country (2023-2028) & (K Units)
Table 72. South America Nivolumab Injection Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Nivolumab Injection Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Nivolumab Injection Sales by Type (2017-2022) & (K Units)
Table 75. South America Nivolumab Injection Sales by Type (2023-2028) & (K Units)
Table 76. South America Nivolumab Injection Sales by Application (2017-2022) & (K Units)
Table 77. South America Nivolumab Injection Sales by Application (2023-2028) & (K Units)
Table 78. Middle East & Africa Nivolumab Injection Sales by Region (2017-2022) & (K Units)
Table 79. Middle East & Africa Nivolumab Injection Sales by Region (2023-2028) & (K Units)
Table 80. Middle East & Africa Nivolumab Injection Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Nivolumab Injection Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Nivolumab Injection Sales by Type (2017-2022) & (K Units)
Table 83. Middle East & Africa Nivolumab Injection Sales by Type (2023-2028) & (K Units)
Table 84. Middle East & Africa Nivolumab Injection Sales by Application (2017-2022) & (K Units)
Table 85. Middle East & Africa Nivolumab Injection Sales by Application (2023-2028) & (K Units)
Table 86. Nivolumab Injection Raw Material
Table 87. Key Manufacturers of Nivolumab Injection Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Nivolumab Injection Typical Distributors
Table 91. Nivolumab Injection Typical Customers
List of Figures
Figure 1. Nivolumab Injection Picture
Figure 2. Global Nivolumab Injection Revenue Market Share by Type in 2021
Figure 3. 100IU
Figure 4. 50IU
Figure 5. Other
Figure 6. Global Nivolumab Injection Revenue Market Share by Application in 2021
Figure 7. Unresectable Melanoma
Figure 8. Metastatic Melanoma
Figure 9. Metastatic Squamous NSCLC
Figure 10. Classical Hodgkin Lymphoma
Figure 11. Renal Cell Carcinoma
Figure 12. Other
Figure 13. Global Nivolumab Injection Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 14. Global Nivolumab Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Nivolumab Injection Sales (2017-2028) & (K Units)
Figure 16. Global Nivolumab Injection Price (2017-2028) & (US$/Unit)
Figure 17. Global Nivolumab Injection Production Capacity (2017-2028) & (K Units)
Figure 18. Global Nivolumab Injection Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Nivolumab Injection Market Drivers
Figure 20. Nivolumab Injection Market Restraints
Figure 21. Nivolumab Injection Market Trends
Figure 22. Global Nivolumab Injection Sales Market Share by Manufacturer in 2021
Figure 23. Global Nivolumab Injection Revenue Market Share by Manufacturer in 2021
Figure 24. Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Nivolumab Injection Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Nivolumab Injection Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Nivolumab Injection Sales Market Share by Region (2017-2028)
Figure 28. Global Nivolumab Injection Revenue Market Share by Region (2017-2028)
Figure 29. North America Nivolumab Injection Revenue (2017-2028) & (USD Million)
Figure 30. Europe Nivolumab Injection Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Nivolumab Injection Revenue (2017-2028) & (USD Million)
Figure 32. South America Nivolumab Injection Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Nivolumab Injection Revenue (2017-2028) & (USD Million)
Figure 34. Global Nivolumab Injection Sales Market Share by Type (2017-2028)
Figure 35. Global Nivolumab Injection Revenue Market Share by Type (2017-2028)
Figure 36. Global Nivolumab Injection Price by Type (2017-2028) & (US$/Unit)
Figure 37. Global Nivolumab Injection Sales Market Share by Application (2017-2028)
Figure 38. Global Nivolumab Injection Revenue Market Share by Application (2017-2028)
Figure 39. Global Nivolumab Injection Price by Application (2017-2028) & (US$/Unit)
Figure 40. North America Nivolumab Injection Sales Market Share by Type (2017-2028)
Figure 41. North America Nivolumab Injection Sales Market Share by Application (2017-2028)
Figure 42. North America Nivolumab Injection Sales Market Share by Country (2017-2028)
Figure 43. North America Nivolumab Injection Revenue Market Share by Country (2017-2028)
Figure 44. United States Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Nivolumab Injection Sales Market Share by Type (2017-2028)
Figure 48. Europe Nivolumab Injection Sales Market Share by Application (2017-2028)
Figure 49. Europe Nivolumab Injection Sales Market Share by Country (2017-2028)
Figure 50. Europe Nivolumab Injection Revenue Market Share by Country (2017-2028)
Figure 51. Germany Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Nivolumab Injection Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Nivolumab Injection Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Nivolumab Injection Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Nivolumab Injection Revenue Market Share by Region (2017-2028)
Figure 60. China Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Nivolumab Injection Sales Market Share by Type (2017-2028)
Figure 67. South America Nivolumab Injection Sales Market Share by Application (2017-2028)
Figure 68. South America Nivolumab Injection Sales Market Share by Country (2017-2028)
Figure 69. South America Nivolumab Injection Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Nivolumab Injection Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Nivolumab Injection Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Nivolumab Injection Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Nivolumab Injection Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Nivolumab Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Nivolumab Injection in 2021
Figure 81. Manufacturing Process Analysis of Nivolumab Injection
Figure 82. Nivolumab Injection Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のニボルマブ注射市場2022年：100IU、50IU、その他(Global Nivolumab Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のニボルマブ注射市場2022年：100IU、50IU、その他

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp